Used by |
as |
Name |
Version |
2.16.840.1.113883.10.12.321 |
Containment |
CDA Participant (Body)
|
2005‑09‑07 |
2.16.840.1.113883.10.12.301 |
|
CDA Act
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.301, please check
|
2.16.840.1.113883.10.12.300 |
|
CDA Clinical Statement
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.300, please check
|
2.16.840.1.113883.10.12.201 |
|
CDA Section
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.201, please check
|
2.16.840.1.113883.10.12.202 |
|
CDA StructuredBody
|
2005‑09‑07 |
2.16.840.1.113883.10.12.112 |
|
CDA component
|
2005‑09‑07 |
2.16.840.1.113883.3.1937.777.63.10.17 |
|
Prescrizione farmaceutica
|
2022‑06‑22 16:53:44 |
2.16.840.1.113883.3.1937.777.63.10.153 |
|
Allergie (RAP) (Allergie(RAP))
|
2022‑09‑22 15:46:20 |
2.16.840.1.113883.3.1937.777.63.10.16 |
|
CDA ClinicalDocument (with StructuredBody)
|
2022‑06‑21 10:58:46 |
2.16.840.1.113883.3.1937.777.63.10.22 |
|
CDA Section
|
2022‑06‑23 14:04:37 |
2.16.840.1.113883.3.1937.777.63.10.237 |
|
CDA ClinicalDocument (with StructuredBody)
|
2022‑09‑30 10:06:14 |
2.16.840.1.113883.10.12.302 |
|
CDA Encounter
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.302, please check
|
2.16.840.1.113883.10.12.303 |
|
CDA Observation
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.303, please check
|
2.16.840.1.113883.10.12.304 |
|
CDA ObservationMedia
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.304, please check
|
2.16.840.1.113883.10.12.305 |
|
CDA Organizer
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.305, please check
|
2.16.840.1.113883.10.12.306 |
|
CDA Procedure
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.306, please check
|
2.16.840.1.113883.10.12.307 |
|
CDA RegionOfInterest
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.307, please check
|
2.16.840.1.113883.10.12.308 |
|
CDA SubstanceAdministration
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.308, please check
|
2.16.840.1.113883.10.12.309 |
|
CDA Supply
|
2005‑09‑07 |
|
Circular reference found with 2.16.840.1.113883.10.12.309, please check
|
2.16.840.1.113883.2.9.10.1.5.4.2 |
|
Terapia farmacologica somministrata (LDO)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.5.4.4 |
|
Terapia farmacologica richiesta (LDO)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.1 |
|
Motivo della visita (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.10 |
|
Terapia Farmacologica Consigliata (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.2 |
|
Terapia Farmacologica In Atto (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.3 |
|
Prestazioni Amministrative Eseguite (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.4 |
|
Procedura Operativa Eseguita Procedure (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.5 |
|
Procedura Operativa Eseguita SubstanceAdministration (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.6 |
|
Procedura Operativa Eseguita Observation (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.7 |
|
Procedura Operativa Eseguita Act (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.8 |
|
Diagnosi (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.2.9.10.1.9.4.9 |
|
Accertamenti e Controlli Consigliati (RSA)
|
2018‑04‑11 |
2.16.840.1.113883.3.1937.777.63.10.140 |
|
CDA Procedure RAP
|
2022‑09‑21 16:39:15 |
2.16.840.1.113883.3.1937.777.63.10.146 |
|
Tipo campione RAP
|
2022‑09‑22 08:56:32 |
2.16.840.1.113883.3.1937.777.63.10.147 |
|
Procedura di Dissezione del campione RAP (Procedura_dissezione_campione_RAP)
|
2022‑09‑22 09:49:22 |
2.16.840.1.113883.3.1937.777.63.10.191 |
|
Oggetti correlati - Oss. Macro. - RAP (Oggetti correlati - Oss. Macro. - RAP)
|
2022‑09‑26 17:34:38 |
2.16.840.1.113883.3.1937.777.63.10.208 |
|
Oggetti correlati - Oss. Micro. - RAP (Oggetti correlati - Oss. Micro. - Oggetti correlati - Oss. Micro. - RAPRAP)
|
2022‑09‑27 12:28:16 |
2.16.840.1.113883.3.1937.777.63.10.234 |
|
Dimensione cellule tumorali isolate (dimCelluleTumoraliIsolate)
|
2022‑09‑27 16:24:05 |
2.16.840.1.113883.3.1937.777.63.10.25 |
|
Esenzioni Applicate
|
2022‑06‑23 14:45:56 |
2.16.840.1.113883.2.9.10.1.6.45 |
|
Accertamenti (Organizer) (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.27 |
|
Accertamenti (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.1 |
|
Verbale di Pronto Soccorso (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.3.1937.777.63.10.15 |
|
Prescrizione farmaceutica
|
2022‑06‑21 09:01:33 |
2.16.840.1.113883.2.9.10.1.6.51 |
|
Encounter Activity (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.50 |
|
Encounters (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.67 |
|
Post Dimissione (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.66 |
|
Dimissione (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.2.9.10.1.6.24 |
|
Dimissione (VPS)
|
2018‑03‑19 |
2.16.840.1.113883.3.1937.777.63.10.158 |
Containment |
CDA Participant (Body)
|
2022‑09‑25 15:00:42 |
2.16.840.1.113883.3.1937.777.63.10.159 |
Containment |
CDA Participant (Body)
|
2022‑09‑25 15:08:55 |
2.16.840.1.113883.3.1937.777.63.10.160 |
Containment |
CDA Participant (Body)
|
2022‑09‑25 15:09:53 |
2.16.840.1.113883.3.1937.777.63.10.301 |
Containment |
CDA Participant (Body)
|
2023‑02‑14 18:30:54 |
2.16.840.1.113883.3.1937.777.63.10.5 |
Containment |
Participant persona (VPS)
|
2018‑03‑19 |